Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the EBITDA margin high or low?
The EBITDA margin of 1.76% is 49% below its 5-year average of 3.45%, around the middle of its 5-year range (-2.56%–8.42%).
7.07% below its 12-month average of 1.89%.
Reported quarterly EBITDA margin; no daily interpolation.
EBITDA MARGIN
1.76%
EBITDA MARGIN AVG TTM
1.89%
EBITDA MARGIN AVG 3Y
2.55%
EBITDA MARGIN AVG 5Y
3.45%
EBITDA MARGIN AVG 10Y
5.42%
EBITDA MARGIN AVG 15Y
5.53%
EBITDA MARGIN AVG 20Y
5.48%
CURRENT VS TTM AVG
-7.07%
CURRENT VS 3Y AVG
-30.95%
CURRENT VS 5Y AVG
-48.92%
CURRENT VS 10Y AVG
-67.55%
CURRENT VS 15Y AVG
-68.16%
CURRENT VS 20Y AVG
-67.91%
Market Cap
$49.35B
EBITDA Margin
23.08%
TTM Avg
23.14%
3Y Avg
23.23%
5Y Avg
22.53%
Market Cap
$49.93B
EBITDA Margin
29.55%
TTM Avg
28.88%
3Y Avg
30.96%
5Y Avg
31.73%
Market Cap
$42.81B
EBITDA Margin
18.31%
TTM Avg
11.44%
3Y Avg
6.73%
5Y Avg
5.67%
Market Cap
$42.67B
EBITDA Margin
21.04%
TTM Avg
21.29%
3Y Avg
20.90%
5Y Avg
20.09%
Market Cap
$41.48B
EBITDA Margin
25.43%
TTM Avg
26.12%
3Y Avg
26.05%
5Y Avg
25.37%
Market Cap
$55.68B
EBITDA Margin
-147.07%
TTM Avg
-132.24%
3Y Avg
-66.39%
5Y Avg
-46.73%
Market Cap
$41.04B
EBITDA Margin
34.08%
TTM Avg
33.18%
3Y Avg
32.37%
5Y Avg
31.82%
| NAME | MARKET CAP | EBITDA MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Humana Inc. (HUM) | $48.40B | 1.76% | 1.89% | 2.55% | 3.45% |
| Becton, Dickinson and Company (BDX)vs › | $49.35B | 23.08% | 23.14% | 23.23% | 22.53% |
| Edwards Lifesciences Corporation (EW)vs › | $49.93B | 29.55% | 28.88% | 30.96% | 31.73% |
| Teva Pharmaceutical Industries Limited (TEVA)vs › | $42.81B | 18.31% | 11.44% | 6.73% | 5.67% |
| IQVIA Holdings Inc. (IQV)vs › | $42.67B | 21.04% | 21.29% | 20.90% | 20.09% |
| Agilent Technologies, Inc. (A)vs › | $41.48B | 25.43% | 26.12% | 26.05% | 25.37% |
| Moderna, Inc. (MRNA)vs › | $55.68B | -147.07% | -132.24% | -66.39% | -46.73% |
| IDEXX Laboratories, Inc. (IDXX)vs › | $41.04B | 34.08% | 33.18% | 32.37% | 31.82% |
| Cardinal Health, Inc. (CAH)vs › | $56.32B | 1.40% | 1.39% | 1.08% | 0.86% |
| Alnylam Pharmaceuticals, Inc. (ALNY)vs › | $34.80B | 15.00% | 4.83% | -18.55% | -52.26% |
Gross Margin
13.7%
EBITDA Margin
1.8%
Operating Margin
1.4%
Net Margin
0.9%
Formula: EBITDA Margin = (EBITDA / Revenue) × 100
Why EBITDA Margin matters:
EBITDA Margin = EBITDA / Revenue
EBITDA margin measures operating profitability before interest, taxes, depreciation, and amortization as a percentage of revenue.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | EBITDA MARGIN |
|---|---|
| 2026-06-30 | 3.72% |
| 2026-03-31 | 4.47% |
| 2025-12-31 | -2.56% |
| 2025-09-30 | 0.96% |
| 2025-06-30 | 2.88% |
| 2025-03-31 | 5.80% |
| 2024-12-31 | -2.26% |
| 2024-09-30 | 2.99% |
| 2024-06-30 | 3.87% |
| 2024-03-31 | 4.16% |
| 2023-12-31 | -1.42% |
| 2023-09-30 | 5.00% |
| 2023-06-30 | 5.53% |
| 2023-03-31 | 6.79% |
| 2022-12-31 | 0.63% |
| 2022-09-30 | 6.64% |
| 2022-06-30 | 5.63% |
| 2022-03-31 | 5.93% |
| 2021-12-31 | 0.62% |
| 2021-09-30 | 8.42% |
| 2021-06-30 | 4.56% |
| 2021-03-31 | 5.95% |
| 2020-12-31 | -1.53% |
| 2020-09-30 | 9.72% |
| 2020-06-30 | 14.47% |
| 2020-03-31 | 4.59% |
| 2019-12-31 | 4.48% |
| 2019-09-30 | 6.45% |
| 2019-06-30 | 8.50% |
| 2019-03-31 | 5.49% |
| 2018-12-31 | 4.04% |
| 2018-09-30 | 7.33% |
| 2018-06-30 | 6.96% |
| 2018-03-31 | 6.30% |
| 2017-12-31 | 5.35% |
| 2017-09-30 | 7.36% |
| 2017-06-30 | 9.01% |
| 2017-03-31 | 6.61% |
| 2016-12-31 | -2.49% |
| 2016-09-30 | 7.78% |
| 2016-06-30 | 5.37% |
| 2016-03-31 | 4.46% |
| 2015-12-31 | 2.68% |
| 2015-09-30 | 5.65% |
| 2015-06-30 | 6.61% |
| 2015-03-31 | 6.20% |
| 2014-12-31 | 3.33% |
| 2014-09-30 | 5.42% |
| 2014-06-30 | 6.15% |
| 2014-03-31 | 6.77% |
| 2013-12-31 | 0.64% |
| 2013-09-30 | 6.71% |
| 2013-06-30 | 7.34% |
| 2013-03-31 | 7.93% |
| 2012-12-31 | 4.00% |
| 2012-09-30 | 7.80% |
| 2012-06-30 | 6.66% |
| 2012-03-31 | 4.58% |
| 2011-12-31 | 4.32% |
| 2011-09-30 | 8.31% |
| 2011-06-30 | 8.63% |
| 2011-03-31 | 6.23% |
| 2010-12-31 | 2.88% |
| 2010-09-30 | 8.22% |
| 2010-06-30 | 7.05% |
| 2010-03-31 | 5.72% |
| 2009-12-31 | 6.14% |
| 2009-09-30 | 6.89% |
| 2009-06-30 | 6.34% |
| 2009-03-31 | 4.56% |
| 2008-12-31 | 4.29% |
| 2008-09-30 | 4.74% |
| 2008-06-30 | 5.15% |
| 2008-03-31 | 2.51% |
| 2007-12-31 | 6.42% |
| 2007-09-30 | 8.24% |
| 2007-06-30 | 6.13% |
| 2007-03-31 | 2.45% |
| 2006-12-31 | 4.96% |
| 2006-09-30 | 5.08% |
| 2006-06-30 | 3.27% |
| 2006-03-31 | 3.53% |
| 2005-12-31 | 3.63% |
| 2005-09-30 | 2.64% |
| 2005-06-30 | 4.42% |
| 2005-03-31 | 4.31% |
| 2004-12-31 | 3.00% |
| 2004-09-30 | 5.00% |
| 2004-06-30 | 4.36% |
| 2004-03-31 | 3.93% |
| 2003-12-31 | 4.00% |
| 2003-09-30 | 3.87% |
| 2003-06-30 | 4.38% |
| 2003-03-31 | 3.14% |
| 2002-12-31 | 0.97% |
| 2002-09-30 | 3.78% |